| Tag | Content |
|---|
EnhancerAtlas ID | HS091-46863 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr8:131218300-131220350 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EHF | MA0598.2 | chr8:131218927-131218939 | TACTTCCGGGTG | - | 6.62 | | ELF3 | MA0640.1 | chr8:131218926-131218939 | ATACTTCCGGGTG | - | 6.32 | | ELF4 | MA0641.1 | chr8:131218927-131218939 | TACTTCCGGGTG | - | 6.07 | | ELF5 | MA0136.2 | chr8:131218927-131218938 | TACTTCCGGGT | - | 6.62 | | RUNX3 | MA0684.1 | chr8:131219084-131219094 | TTTGCGGTTT | - | 6.02 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09147 | chr8:131202941-131227373 | CD14 | | SE_45598 | chr8:131218037-131222056 | Osteoblasts |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH08I130205 | chr8 | 131218047 | 131220245 |
|
Enhancer Sequence | TATGTATGAT TTTTTAAATA GAAGGAGTTA AAAATAAACC TTTCCCTCTT ACCCACCCAC 60
CAACCCACAT GGATAGATCA CATTTCACAA AATGTCCCAC AGTATTAATT GGTAGTGAGG 120
CAGTGAGGCA TGTCAGGAAA TAAGGGGATA CCTGGTAGAT CAAACGCTGA AAACTGCCAA 180
TGATTGATGA CCATTTTTTT AAAAGATAAG GTTTTAAAAA TGCATTATAT AGTTCAGGGC 240
ACCCAGAAGC TACCAATTTT ACCATTAGGC ACATCCATGC TCTCCATACT TTTTAACATT 300
TCAAAGAAGA ACTTGAGAAA TAATCTGCTG GCTACAAATC TAGATCCAAC CTGTACATTA 360
TCAGATATTC TTATTTGAGG GGAAAGAAAA GAAGAAAAAT AAAAAAAAAA ACAACTTTAA 420
CACAAACCAC AATACCCTAC AGTCAGAGAT TGCAAACAGG AAATGCTATG CAGATGGAGA 480
AATCTTTGCT TTGCTTCAAC AGCTCTGAAG CAATAACTGC CCTCCAACTG TTTAATGAGA 540
CTCAAGCTCT TATGCAAGCT ATAGAATTGT CCAAAGGCCT CCGGAGAGAA GAAACCAGAT 600
GCATGGTGAG TCCTGGCTGA CCTAGAATAC TTCCGGGTGA CTCCCACTAT TTAAAAAATA 660
ATTTATATAC ATTTTCTAAA ACCATTGCTG CCTTGGGACT TTCAAAGGGT ATGGCATTTA 720
AATGGTTTTC CTCTGTCCAT TGAGAATCTA TTTCAATCCA CCAGTTATTC CTTTCCTGAC 780
CCATTTTGCG GTTTTGGTAT TAAATGGATG CAAATCTCTG CTGACTCCTT AACTTCTTTG 840
CTAGGATCAC AGGAATGATG CCTGATGCCA GGAGTAGAGC AGACCCAGCA TTGCTTAGCA 900
AGTAATGATT TTATTGGTTT CCTTTTCATG GTTAAAAAAA AAAGGTTGAA CGTAATTTTT 960
CAGTACTATA CATTTAATCA AACATATAAC AAAACCACTT AGAAACAGCT AAAACTCAAG 1020
AGCATTCTGC TTCCTTTTTC TTTTTTTAAA CAAGAAAGCT GCATTGCAAA GAAAGTCTTT 1080
ATTATTAATA CACTAACTAC TAAGGGGCAC TCAAAGTGGA AGGAATGGAA TCTATAAAGG 1140
CATGGAAGCG TGAAATGGTA TATATTCCAT GAACAACAAA TCGTTTGTTA TGTCTGGAGT 1200
TGGCTTTGAT TAGGAAGGCA TCTTTAATGA GAGGAAGGAT AAGTTTAGAG AGATTGCAAG 1260
GCAACTAAAT AAATATTTAA AAAATGTTTT TAAAAATGTC ATTATCTGTT AAGTACATGC 1320
TACGAACTGA ATGCTTTCAT AGGTATTTCA CATAAATTAT TTCTAAAAAT GCCACCAGAA 1380
TGGCAACTCC AAGAGGATAC GGCCCTTGTC TGTGTTCTTC TTACTGCTGC ATCCCTACAG 1440
CCTACCCACA GTGCTTATGT AGAACCCTAA TAAGTAACAG AATGAATCAT AAATGAACAC 1500
AAGGAGGGAT TACTAAACCC TTTTTACAAA AATGAAGAAA CCAAGACTCA AAGAACTCAA 1560
CAAGCCCACA CAAGTAAGAT GCTGAGTATT TTAATACAGG CCTCATTAAA AATCAAAACC 1620
CATGCACTTG TAAGTATGCC ACAAATATAG TAAAAACAAC AGCAATAGAA TAGATCTTGT 1680
CCACATTTCT CTGGCTTCTC ACCACTAAGA GGCAGCATTC CCTAGATATA TTCAATCATG 1740
ACAACTAGAC TCACTTCTGG GAGGAAATAG CTAATCATTC CTACTTTTAT GGAATAGCAA 1800
CCACATATAG GACTTCAATT AGAGGAAGAA ATTAGAAAAC CTATTAAAGT GCGAAGGAAG 1860
CAGGACTGAG GACTGCAGAT CAGTTGGCTC AAAGAGTATC AGGAAGTGAG TTTGATTTGT 1920
GTTCTGCACA TTTGTTTTAT GCTGAAATTT TTATGTAACA ATGTATACTA AACACTTTCC 1980
CCTACTTTTC TCTCCTTGAT AATAATTTGA TAGGTTATAC TTTTATTTAA ACTTATTTTG 2040
AAAAAATTAT 2050
|
